Long term outcome of twin-twin transfusion syndrome
R B Cincottaa, P H Grayb c, G Phythianb, Y M Rogersc, F Y Chana
a Department of
Maternal-Fetal Medicine, Mater Mother's Hospital, Raymond Terrace,
South Brisbane, Queensland, Australia, b Department of Neonatology, c Growth and Development Unit,
Mater Children's Hospital, Raymond Terrace, South Brisbane,
Queensland, Australia
Correspondence to: Dr Cincotta, Department of Maternal-Fetal Medicine, Raymond Terrace, South Brisbane, Queensland 4101, Australia 1neoap{at}mater.org.au
Accepted 3 February
2000
AIMS
To compare the
perinatal mortality and morbidity of infants with twin-twin transfusion
syndrome (TTTS) with those of gestation matched twin controls and to
assess the neurodevelopmental outcome of surviving twins with TTTS.
METHODS
A cohort of 17 consecutive pregnancies with TTTS was enrolled over three years
together with gestation matched twin pregnancies unaffected by TTTS.
Serial amnioreduction for the TTTS pregnancies was performed as
appropriate. Perinatal death and neonatal morbidities were recorded for
both the TTTS cohort and controls. The TTTS survivors had
neurodevelopmental follow up to at least 2 years of age.
RESULTS
In 12 of the
pregnancies, serial amniocenteses were performed, but, in five, the
infants were born before intervention. The mean gestational age at
delivery was 29.1 weeks (range 23-36). There were five intrauterine
deaths in the TTTS cohort and six neonatal deaths (survival 68%). In
the control group, there was one intrauterine death and five neonatal
deaths (survival 82%). Infants in the TTTS group had a greater
requirement for inotropes (p = 0.04) and a higher incidence of renal
failure (p = 0.005). Periventricular leucomalacia and cerebral
atrophy were seen in 17% of the TTTS group, but none of the controls
(p = 0.03). The 23 surviving TTTS infants were all followed up, with
22% having significant neurological morbidity: cerebral palsy and
global developmental delay.
CONCLUSIONS
Twins with
TTTS have high perinatal mortality and neonatal morbidity, and long
term neurodevelopmental morbidity in survivors is high. Further
investigation into the pathogenesis and management of TTTS is required.
Keywords: twin-twin transfusion syndrome; amnioreduction; morbidity; neurodevelopmental outcome
© 2000 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Pharoah, P.O.D., Dundar, Y.
(2009). Monozygotic twinning, cerebral palsy and congenital anomalies. Hum Reprod Update
0: dmp019v1-dmp019
[Abstract] [Full Text] -
Senat, M.-V., Deprest, J., Boulvain, M., Paupe, A., Winer, N., Ville, Y.
(2004). Endoscopic Laser Surgery versus Serial Amnioreduction for Severe Twin-to-Twin Transfusion Syndrome. NEJM
351: 136-144
[Abstract] [Full Text] -
CHISWICK, M.
(2000). Assessing outcomes in twin-twin transfusion syndrome. Arch. Dis. Child. Fetal Neonatal Ed.
83: 165F-167
[Full Text]
eLetters:
Read all eLetters
- Twin to twin transfusion syndrome.
- THHG Koh, et al.
- Fetal Neonatal Ed. Online, 17 Nov 2000 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



